PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain

详细信息    查看全文

• 作者：Yanju Bao ; Wei Hou ; Rui Liu ; Yebo Gao ; Xiangying Kong ; Liping Yang…
• 关键词：Proteinase ; activated receptor 2 ; Brain ; derived neurotrophic factor ; Nuclear factor ; κB ; Glutamatergic transmission ; Bone cancer pain
• 刊名：Molecular Pain
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：10
• 期：1
• 全文大小：964 KB
• 参考文献：1. van den Beuken-van Everdingen, MH, de Rijke, JM, Kessels, AG, Schouten, HC, van Kleef, M, Patijn, J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18: pp. 1437-1449 CrossRef
  2. Mantyh, P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154: pp. S54-62 CrossRef
  3. Wang, XW, Hu, S, Mao-Ying, QL, Li, Q, Yang, CJ, Zhang, H, Mi, WL, Wu, GC, Wang, YQ (2012) Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats. Mol Brain 5: pp. 21 CrossRef
  4. Mao-Ying, QL, Wang, XW, Yang, CJ, Li, X, Mi, WL, Wu, GC, Wang, YQ (2012) Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain 5: pp. 16 CrossRef
  5. Wang, XW, Li, TT, Zhao, J, Mao-Ying, QL, Zhang, H, Hu, S, Li, Q, Mi, WL, Wu, GC, Zhang, YQ, Wang, YQ (2012) Extracellular signal-regulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats. Neuroscience 217: pp. 172-181 CrossRef
  6. Ke, C, Li, C, Huang, X, Cao, F, Shi, D, He, W, Bu, H, Gao, F, Cai, T, Hinton, AO, Tian, Y (2013) Protocadherin20 promotes excitatory synaptogenesis in dorsal horn and contributes to bone cancer pain. Neuropharmacology 75C: pp. 181-190 CrossRef
  7. Yanagisawa, Y, Furue, H, Kawamata, T, Uta, D, Yamamoto, J, Furuse, S, Katafuchi, T, Imoto, K, Iwamoto, Y, Yoshimura, M (2010) Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord. Mol Pain 6: pp. 38 CrossRef
  8. Lu, Y, Christian, K, Lu, B (2008) BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol Learn Mem 89: pp. 312-323 CrossRef
  9. Trang, T, Beggs, S, Salter, MW (2011) Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 7: pp. 99-108 CrossRef
  10. Kobayashi, H, Yokoyama, M, Matsuoka, Y, Omori, M, Itano, Y, Kaku, R, Morita, K, Ichikawa, H (2008) Expression changes of multiple brain-derived neurotrophic factor transcripts in selective spinal nerve ligation model and complete Freund’s adjuvant model. Brain Res 1206: pp. 13-19 CrossRef
  11. Rothmeier, AS, Ruf, W (2012) Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol 34: pp. 133-149 CrossRef
  12. Bao, Y, Hou, W, Hua, B (2014) Protease-activated receptor 2 signalling pathways: a role in pain processing. Expert Opin Ther Targets 18: pp. 15-27 CrossRef
  13. Liu, S, Liu, YP, Yue, DM, Liu, GJ (2013) Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain. Eur J Pain.
  14. Lee, KM, Kang, BS, Lee, HL, Son, SJ, Hwang, SH, Kim, DS, Park, JS, Cho, HJ (2004) Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 19: pp. 3375-3381 CrossRef
  15. Sun, T, Luo, J, Jia, M, Li, H, Li, K, Fu, Z (2012) Small interfering RNA-mediated knockdown of NF-kappaBp65 attenuates neuropathic pain following peripheral nerve injury in rats. Eur J Pharmacol 682: pp. 79-85 CrossRef
  16. Boersma, MC, Dresselhaus, EC, De Biase, LM, Mi
• 刊物主题：Pain Medicine; Molecular Medicine;
• 出版者：BioMed Central
• ISSN：1744-8069

文摘

Background Bone cancer pain is currently a major clinical challenge for the management of cancer patients, and the cellular and molecular mechanisms underlying the spinal sensitization remain unclear. While several studies demonstrated the critical role of proteinase-activated receptor (PAR2) in the pathogenesis of several types of inflammatory or neuropathic pain, the involvement of spinal PAR2 and the pertinent signaling in the central sensitization is not determined yet in the rodent model of bone cancer pain. Findings Implantation of tumor cells into the tibias induced significant thermal hyperalgesia and mechanical allodynia, and enhanced glutamatergic strength in the ipsilateral dorsal horn. Significantly increased brain-derived neurotrophic factor (BDNF) expression was detected in the dorsal horn, and blockade of spinal BDNF signaling attenuated the enhancement of glutamatergic strength, thermal hyperalgesia and mechanical allodynia in the rats with bone cancer pain. Significantly increased spinal PAR2 expression was also observed, and inhibition of PAR2 signaling ameliorated BDNF upsurge, enhanced glutamatergic strength, and thermal hyperalgesia and mechanical allodynia. Inhibition of NF-κB pathway, the downstream of PAR2 signaling, also significantly decreased the spinal BDNF expression, glutamatergic strength of dorsal horn neurons, and thermal hyperalgesia and mechanical allodynia. Conclusion The present study demonstrated that activation of PAR2 triggered NF-κB signaling and significantly upregulated the BDNF function, which critically contributed to the enhancement of glutamatergic transmission in spinal dorsal horn and thermal and mechanical hypersensitivity in the rats with bone cancer. This indicated that PAR2 - NF-κB signaling might become a novel target for the treatment of pain in patients with bone cancer.